Medexus Pharmaceuticals Inc T.MDP

I think people r over reacting ...

[Rockafellow2]

To a 5% drop in revenue.
Dropping 30% in sp is not warranted.
Imo

[zwerp2000]

You're missing the big picture. Their big revenue driver, IXINITY, is getting slashed big time. So much so they are materially cutting salesforce and efforts to sell it. That is not good at all. This means that revenues will continue to decline as will losses. The other drugs in their portfolio are nothing great so don't expect those to help. Management is a bunch of clowns clearly

[Napcoo]

The sales were hired for the treo launch, and assigned to other products, they were desperate to increase revenue to be able to be able to refinance with BMO, and raise by selling shares, now that the debt pressure is reduced, and treo is no where near, I think this is a negative sign of Treo. But the share is very cheap, fingers are itching, will wait